Athira Pharma to Join June Conferences

Athira Pharma, Inc., a biopharmaceutical company in the late stages of clinical development, has announced its participation in two upcoming investor conferences in June 2024. These events will offer updates on the company’s progress in developing treatments aimed at improving neuronal health and combating neurodegenerative diseases.

The company will first attend the Jefferies Healthcare Conference in New York City. This event is scheduled for June 5, 2024, and Athira’s management will participate in a fireside chat from 4:30 p.m. to 4:55 p.m. ET. The second event is the Goldman Sachs 45th Annual Healthcare Conference in Miami, set for June 12, 2024. Here, the management will engage in another fireside chat from 2:00 p.m. to 2:35 p.m. ET. Both events will be held in prestigious venues: the Marriott Marquis in New York City and the Loews Miami Beach Hotel in Miami, respectively. Live webcasts of these discussions will be available on Athira's website, and replays will be accessible for at least 30 days post-event.

Athira Pharma is headquartered in the Seattle area and focuses on developing small molecules to improve neuronal health and slow down neurodegenerative processes. One of its key projects includes a Phase 2/3 LIFT-AD trial for the treatment of mild-to-moderate Alzheimer’s disease, with topline data expected in the latter half of 2024. The company aims to change the treatment landscape for neurological diseases through its therapeutic candidates that modulate the neurotrophic HGF system. 

Fosgonimeton is one of Athira’s prominent therapeutic candidates currently under evaluation. It targets the HGF system to potentially treat Alzheimer’s disease. Athira's work extends to treating other neurodegenerative diseases, including Parkinson’s disease and dementia with Lewy bodies. The company’s goal is to advance these candidates through various stages of clinical trials and bring them closer to market approval.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!